Regimens combining fludarabine with cyclophosphamide and mitoxantrone or doxorubicin have shown to be an effective therapy for elderly patients with advanced-stage low-grade non-Hodgkin's lymphomas (LG-NHL) although complicated by frequent treatment-related neutropenia and infections. We evaluated the efficacy and toxicity of a low-dose fludarabine-based combination regimen (mini-FLEC) in 20 elderly patients with advanced LG-NHL.

Bocchia, M.-., Gentili, S., Forconi, F., LE NOCI, M., Tozzi, M., Lauria, F. (2003). Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC). HAEMATOLOGICA, 88(3), 358-360.

Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC)

BOCCHIA M-;FORCONI F.;LAURIA F.
2003-01-01

Abstract

Regimens combining fludarabine with cyclophosphamide and mitoxantrone or doxorubicin have shown to be an effective therapy for elderly patients with advanced-stage low-grade non-Hodgkin's lymphomas (LG-NHL) although complicated by frequent treatment-related neutropenia and infections. We evaluated the efficacy and toxicity of a low-dose fludarabine-based combination regimen (mini-FLEC) in 20 elderly patients with advanced LG-NHL.
2003
Bocchia, M.-., Gentili, S., Forconi, F., LE NOCI, M., Tozzi, M., Lauria, F. (2003). Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC). HAEMATOLOGICA, 88(3), 358-360.
File in questo prodotto:
File Dimensione Formato  
2003 Bocchia Haematologica LG-NHL 358.full.pdf

accesso aperto

Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 117.46 kB
Formato Adobe PDF
117.46 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/20461
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo